China Pharma Holdings, Inc. (NYSE:CPHI) has a beta value of 0.77 and has seen 3,049,365 shares traded in the recent trading session. The company, currently valued at $28.95 Million, closed the recent trade at $0.6647 per share which meant it lost $0 on the day or 1.73% during that session. The CPHI stock price is -110.62% off its 52-week high price of $1.4 and 68.41% above the 52-week low of $0.21. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.95 Million shares traded. The 3-month trading volume is 1.98 Million shares.
The consensus among analysts is that China Pharma Holdings, Inc. (CPHI) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.
China Pharma Holdings, Inc. (NYSE:CPHI) trade information
Sporting 2.28% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Jun 25 when the CPHI stock price touched $0.77 or saw a rise of 12.97%. Year-to-date, China Pharma Holdings, Inc. shares have moved 182.98%, while the 5-day performance has seen it change 6.82%. Over the past 30 days, the shares of China Pharma Holdings, Inc. (NYSE:CPHI) have changed 49.18%. Short interest in the company has seen 253.91 Million shares shorted with days to cover at 128.24.
China Pharma Holdings, Inc. (CPHI) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +12.1% over the past 5 years. Earnings growth for 2020 is a modest -92.6% while over the next 5 years, the company’s earnings are expected to increase by 10%.
China Pharma Holdings, Inc. (NYSE:CPHI)’s Major holders
Insiders own 49.66% of the company shares, while shares held by institutions stand at 2.33% with a share float percentage of 4.64%. Investors are also buoyed by the number of investors in a company, with China Pharma Holdings, Inc. having a total of 5 institutions that hold shares in the company. The top two institutional holders are Renaissance Technologies, LLC with over 950.08 Thousand shares worth more than $478.75 Thousand. As of March 30, 2020, Renaissance Technologies, LLC held 2.18% of shares outstanding.
The other major institutional holder is UBS Group AG, with the holding of over 55.83 Thousand shares as of March 30, 2020. The firm’s total holdings are worth over $28.13 Thousand and represent 0.13% of shares outstanding.